http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4483b8cbc0acf74b9b6597822c35cee8
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Roosnek |
| name | Eddy Roosnek |
| given-name | Eddy |
| organization-name | Stem Cell and Bone Marrow Transplant Centre, Division of Hematology; Geneva's University Hospitals and University of Geneva Faculty of Medicine; 4 Rue Gabrielle Perret-Gentil 1205 Geneva Switzerland Division of Hematology, Geneva University Hospital and University of Geneva, Geneva, Switzerland Basel Institute for Immunology, CH 4005, Basel, Switzerland. From the Division of Cardiology (B.R.K., S.M., F.M., N.V., F.M.) and Division of Immunology and Allergology (N.R., E.R.), Department of Medicine, University Hospital, Geneva Medical School, Foundation for Medical Research, Geneva, Switzerland. From Basel Institute for Immunology, Switzerland; Biozentrum der Universität Basel, Switzerland; Unité d'Immunologie de Transplantation, Hôpital cantonal universitaire de Genève, Geneva, Switzerland. From the Division of Immunology and Allergology and the Division of Hematology, University Hospital, Geneva, Switzerland; the Institute for Transfusion Medicine, Heinrich Heine University, Duesseldorf, Germany; the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO; Diagnostic and Therapeutic Hematology, Kantonsspital, Basel, Switzerland; and NCCR Molecular Oncology, Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland. Division of Hematology Department of Internal Medicine Geneva University Hospitals and University of Geneva Switzerland From the Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, University Hospital, Lausanne, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; Multidisciplinary Oncology Center, University Hospital (CHUV), Lausanne, Switzerland; and Division of Immunology and Allergology, University Hospital of Geneva, Geneva, Switzerland. Division of Immunology and Allergology, University Hospital, Geneva, Switzerland From the Division of Immunology, the Division of Oncology and the Division of Hematology, the Department of Internal Medicine, Hôpital Cantonal Universitaire, Geneva, Switzerland; the Lab for Clinical Viro Immunology, CLB, Sanquin Bloodfoundation and Lab for Experimental and Clinical Immunology, AMC, Amsterdam The Netherlands; and the Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. §Department of Internal Medicine, Division of Hematology, Geneva University Hospital, Geneva, Switzerland From the Division of Immunology and Allergology, University of Geneva, Geneva, Switzerland; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, CHUV, Lausanne, Switzerland; Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada; and the Department of Medicine, University of British Columbia, Vancouver, Canada. Division of Hematology, Geneva University Hospital, 1205 Geneva, Switzerland From the Medizinische Klinik und Poliklinik, Abteilung II, Tübingen, Germany; Division of Immunology and Allergology, University of Geneva, Switzerland; National Center for Competence and Research Molecular Oncology, Swiss Institut for Experimental Cancer Research, Epalinges, Switzerland; Abteilung Medizinische Virologie und Epidemiologie der Viruskrankheiten, Tübingen, Germany; and Institut für Zellbiologie Universität Tübingen, Germany. From the Division of Immunology and Allergology, Division of Oncology, and Division of Hematology, Department of Internal Medicine; and Center for Vaccinology and Neonatal Immunology, Department of Pathology and Pediatrics, University Hospital, Geneva, Switzerland. From the Division of Immunology and Allergology and the Division of Hematology and Oncology, University of Geneva, Geneva, Switzerland; the Division of Hematology, Oncology and Immunology, University of Tübingen, Tübingen, Germany; and the Terry Fox Laboratory, British Columbia Cancer Agency, and the Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. §Division of Hematology, Geneva University Hospital, Geneva, Switzerland Department of Oncology, Division of Hematology, Geneva University Hospitals, Geneva, Switzerland; Division of Hematology, Department of Medical Specialties, Geneva University Hospitals, University of Geneva, CH-1211 Geneva 14, Switzerland |
Incoming Links
Total number of triples: 93.